Bone marrow adipose tissue does not express UCP1 during development or adrenergic-induced remodeling by Craft, Clarissa S. et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2019 
Bone marrow adipose tissue does not express UCP1 during 
development or adrenergic-induced remodeling 
Clarissa S. Craft 
Hero Robles 
Madelyn R. Lorenz 
Eric D. Hilker 
Kristann L. Magee 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Clarissa S. Craft, Hero Robles, Madelyn R. Lorenz, Eric D. Hilker, Kristann L. Magee, Thomas L. Andersen, 
William P. Cawthorn, Ormond A. MacDougald, Charles A. Harris, and Erica L. Scheller 
1Scientific RepoRtS |         (2019) 9:17427  | https://doi.org/10.1038/s41598-019-54036-x
www.nature.com/scientificreports
Bone marrow adipose tissue 
does not express UCP1 during 
development or adrenergic-induced 
remodeling
clarissa S. craft1,2, Hero Robles1, Madelyn R. Lorenz1, Eric D. Hilker1, Kristann L. Magee1, 
thomas L. Andersen5,6, William P. cawthorn7, Ormond A. MacDougald8, Charles A. Harris3,4 & 
Erica L. Scheller1,2*
Adipocytes within the skeleton are collectively termed bone marrow adipose tissue (BMAT). BMAT 
contributes to peripheral and local metabolism, however, its capacity for cell-autonomous expression 
of uncoupling protein 1 (UCP1), a biomarker of beige and brown adipogenesis, remains unclear. 
To overcome this, Ucp1-Cre was used to drive diphtheria toxin expression in cells expressing UCP1 
(Ucp1cre+/DTA+). Despite loss of brown adipose tissue, BMAT volume was not reduced in Ucp1cre+/DTA+ 
mice. Comparably, in mTmG reporter mice (Ucp1cre+/mTmG+), Ucp1-Cre expression was absent from BMAT 
in young (3-weeks) and mature (16-weeks) male and female mice. Further, β3-agonist stimulation 
failed to induce Ucp1-Cre expression in BMAT. This demonstrates that BMAT adipocytes are not UCP1-
expressing beige/brown adipocytes. Thus, to identify novel and emerging roles for BMAT adipocytes 
in skeletal and whole-body homeostasis, we performed gene enrichment analysis of microarray data 
from adipose tissues of adult rabbits. Pathway analysis revealed genetic evidence for differences in 
BMAT including insulin resistance, decreased fatty acid metabolism, and enhanced contributions to 
local processes including bone mineral density through candidate genes such as osteopontin. In sum, 
this supports a paradigm by which BMAT adipocytes are a unique subpopulation that is specialized to 
support cells within the skeletal and hematopoietic niche.
Bone marrow adipose tissue (BMAT) is the collection of adipocytes found within medullary cavities of the skele-
ton. In humans, rapid expansion of BMAT begins postnatally with BMAT occupying up to 70% of medullary space 
by age 23, giving bone marrow a yellow appearance1. Cross-sectional clinical studies have associated increased 
BMAT with decreased bone density and increased fracture incidence in elderly populations (reviewed in2). 
However, it is important to highlight that peak bone mass in humans is attained coincident with rapid BMAT 
expansion indicating that BMAT is not uniformly harmful to bone3. Similar to humans, physiological BMAT 
expansion in rodents occurs coincident with bone accrual, and comparison of BMAT across mouse strains reveals 
bone mass and BMAT volume can be positively correlated in states of health. Specifically, C3H/HeJ mice have 
both higher bone mass and BMAT volume compared to C57BL/6J mice4. By contrast, animal studies during 
pathologic conditions have demonstrated that BMAT volume is often, but not always, associated with impaired 
bone mass or quality (reviewed in5). Beyond bone, BMAT has the capacity to function as an endocrine organ 
and site of energy storage and release6,7. Thus, additional characterization of BMAT development, regulation and 
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function during both healthy and pathologic conditions is necessary to facilitate our understanding of BMAT’s 
relationship both to bone and to peripheral metabolism.
Extraskeletal adipocytes are grouped into functional classifications which range from brown or beige, to white 
and pink (reviewed in8). Even within a subclass, for example white adipose tissues (WAT), metabolic responsive-
ness can vary widely between depots reflecting diverse functions of adipocytes in both structural support and 
lipid partitioning (reviewed in9). In post-pubescent mice, BMAT adipocytes have been classified into two catego-
ries, regulated BMAT (rBMAT) and constitutive BMAT (cBMAT) (reviewed in10). Regulated BMAT adipocytes 
reside in diverse, multicellular niches which can include pericytes, hematopoietic cells and osteogenic cells11. 
These cells are capable of lipid droplet remodeling in response to β3-agonist stimulation, however, BMAT lipid 
droplet remodeling is modest and morphologically distinct from ‘beige-like’ remodeling traditionally observed 
in white adipose tissues7. Constitutive BMAT adipocytes reside in homologous cBMAT niches and are relatively 
resistant to adrenergic stimuli7.
Though bone marrow adipocytes generally resemble white adipocytes morphologically, whether BMAT adi-
pocytes are ‘beige-like’ remains unclear. Fundamental characteristics of ‘beige’ adipocytes include their ability to 
remodel from a unilocular to multilocular morphology and their capacity for induced expression of uncoupling 
protein-1 (UCP1), a biomarker of thermogenesis12. UCP1 is a key brown/beige adipocyte protein that resides on 
the inner mitochondrial membrane where its presence allows energy released from fatty acids to be converted 
into heat13. In support of BMAT beiging, adipocytes in the proximal regions of the mouse skeleton (rBMAT) have 
been reported to express markers of brown fat, including Ucp1, at the level of RNA transcript14–17. In vivo, there is 
one report showing a multilocular appearing cell in the lumbar vertebrae of a developing mouse with immuno-
histochemical evidence that this cell expressed UCP1 protein18. Also in vivo, treatment of female C3H/HeJ mice 
with ß3-adrenergic agonist CL316,243 has been shown to induce modest lipid droplet remodeling, resulting in 
a multilocular morphology, within a subpopulation of rBMAT adipocytes7. Finally, lineage tracing has provided 
anecdotal evidence that a subset of BMAT adipocytes have beiging potential. Specifically, BMAT adipocytes have 
been shown to express PdgfRα, a mediator of adipocyte progenitor commitment to a beige adipocyte19, following 
irradiation or rosiglitazone treatment (discussed in20).
Arguing against BMAT beiging includes a limitation in the above mentioned Ucp1 transcript studies. Ucp1 
transcript was measured from RNA acquired from whole bone preparations which are highly heterogeneous 
and susceptible to contamination from extraskeletal adipocyte-containing soft tissues. In addition, the amount 
of Ucp1 transcript detected was significantly less than found in BAT (>10,000 fold)14,16. Second, the majority of 
brown adipocyte progenitors and a minority of beige progenitors express myogenic factor-5 (Myf5)21,22, how-
ever, lineage tracing has shown that BMAT progenitors do not express Myf5 (discussed in20). Finally, there is 
also preliminary in vivo evidence that UCP1 protein expression is absent in BMAT adipocytes. Specifically, a 
methionine-restricted diet was used to induce beiging of white adipocytes. This diet successfully resulted in 
increased UCP1 protein expression in inguinal white adipose tissue (a predominant site of beige adipocytes in 
rodents) but, unlike the findings of Nishino et al.18, failed to induce UCP1 protein expression by IHC in BMAT 
adipocytes20,23. Thus, it is clear that significant controversy exists in the literature regarding this point.
To overcome this, we sought to track UCP1 expression in BMAT at the single cell level using multiple rodent 
models of development and adrenergic-stimulated remodeling. Our laboratory has previously observed BMAT 
adipocytes in adult mice containing multiple lipid droplets using 3D electron microscopy11, as well as modest 
lipid droplet remodeling in response to β3-agonist stimulation7; both are characteristics of beige adipocytes7,11 
and of white adipocytes that are developing or undergoing stimulated lipolysis (reviewed in24). Until now, we had 
not definitively addressed whether BMAT adipocytes are truly beige-like adipocytes as defined by their capacity 
to express UCP1. Clarification of whether some BMAT adipocytes express UCP1 has important implications for 
our understanding of the role of BMAT in skeletal processes including hematopoiesis and bone turnover. Here, 
immunohistochemical studies were coupled with genetic ablation and lineage tracing of UCP1 expressing cells to 
determine whether any BMAT adipocyte population expressing UCP1 exists during development, in adulthood, 
or after systemic β3-adrenergic stimulation. In addition, to define novel pathways that separate BMAT and WAT, 
we performed serial gene enrichment and pathway analysis of microarrays from both white and bone marrow 
adipose tissues.
Results
Bone marrow adipocytes exist within a sinusoidal niche and are predominately unilocular. The 
lipid droplet morphology and localization of BMAT adipocytes in the developing limb was examined in male and 
female C57BL/6J mice. Adipocytes and vascular sinusoids were visualized using perilipin and endomucin immu-
nohistochemistry, respectively. At 3-weeks of age, bone marrow adipocytes were nearly absent in the metaphyseal 
regions of the distal femur and the proximal metaphysis of the tibia. By contrast, prominent marrow adipocyte 
populations were noted in the distal tibia and in both the proximal tibia and distal femoral epiphyses. At 3-weeks 
of age, both unilocular and multilocular adipocytes were found on the exterior of the bone, near the periosteal 
surface (Fig. 1a). Multilocular adipocytes near the periosteum were largely observed in the proximal tibia-fibula 
junction and near the femoral neck. Within the bone marrow, it was observed that endomucin positive endothe-
lium forms a peri-sinusoidal niche for most, if not all, of the bone marrow adipocytes. The predominant mor-
phology of the BMAT adipocytes was a single, large perilipin + lipid droplet with an eccentric nucleus (Fig. 1a). 
However, a subset of the BMAT adipocytes in both femur and tibia had multiple small perilipin positive lipid 
droplets positioned around a central nucleus (Fig. 1a). The frequency of multilocular bone marrow adipocytes 
in 3-week-old mice (~5%) was found to be comparable across all regions of the femur and tibia (Fig. 1b). This 
finding remained constant even in postpubescent animals at 9-weeks of age (Fig. 1b).
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Immunostaining for UCP1 in BMAT is inconclusive. UCP1 protein expression was examined in BMAT 
and peripheral adipose tissues using immunohistochemistry. When calibrated using tissue from Ucp1-knockout 
mice (Fig. 2a), immunostaining for UCP1 was positive in peripheral brown adipocytes of interscapular brown fat 
(BAT) and beige adipocytes within inguinal white adipose tissue (iWAT) (Fig. 2b). Cells with a morphology sim-
ilar to beige adipocytes (multiple small lipid droplets associated with large lipid droplet7) which stained positive 
for UCP1 were also found near the periosteal surface, most commonly seen in the femoral neck and proximal 
tibia-fibula junction. This finding indicates that whole bone RNA preparations are susceptible to contamination 
by UCP1-positive adipocytes near the periosteal surface. Within the bone, UCP1 staining appeared negative 
in tail BMAT regions (cBMAT). However, non-specific staining in BMAT regions rich in hematopoietic cells 
(rBMAT) made definitive conclusions on UCP1 expression in rBMAT challenging (Fig. 2b). Thus, we opted to 
move forward with the two genetic mouse models described below.
Figure 1. Bone marrow adipocytes exist within a sinusoidal niche and are predominately unilocular. (a) 
Representative images of unilocular and multilocular adipocytes located outside the bone, near the periosteal 
bone surface (periosteum) or within the bone marrow of 3-week-old C57BL/6J mouse femurs and tibias 
Hematoxylin and eosin images (top) were acquired at 40X, scale bar is 50 µm. Immunofluorescent confocal 
images (bottom) were acquired at 60X, scale bar is 50 µm. Adipocytes were visualized with α-perilipin antibody 
(red), sinusoids were visualized with α-endomucin antibody (green), and nuclei were visualized with DAPI 
(blue). Unilocular and multilocular adipocytes are indicated by white and black arrowheads, respectively. (b) 
Regional analysis of multilocular adipocyte frequency (relative to total adipocyte number), in 3-week-old and 
9-week-old C57BL/6J mouse bones. Metaphysis (Mp), epiphysis (Ep). Mean ± SD. Sample sizes: 3-week n = 4–6, 
9-week n = 6–7.
Figure 2. Immunostaining for UCP1 in BMAT is inconclusive. (a) IHC of brown adipose tissue (BAT, top) 
and rBMAT (bottom) from Ucp1-knockout mouse (Ucp1-KO, C57BL/6J) using α-UCP1 antibody. Images 
were acquired at 40X, scale bar is 50 µm. (b) Images of brown adipose tissue (BAT), inguinal white adipose 
tissue (iWAT), adipocytes external to the bone, near the periosteal surface (periosteum), cBMAT (tail), and 
rBMAT from C3H/HeJ mice treated with 5 μg CL316,243 per mouse per day for 3-days. Images were acquired 
at 40x (top) or 80x (bottom), scale bar is 50 µm. White boxes in top images show inset for below images. White 
arrowhead indicates non-specific staining. Black arrowhead highlights a multilocular BMAT adipocyte with 
indeterminate UCP1 expression. Black arrow highlights multilocular BAT-like cells near the periosteal surface. 
These cells are positive for UCP1 immunostaining.
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Genetic ablation of UCP1-expressing cells does not cause loss of BMAT at 4-weeks of age. 
Ucp1-Cre expressing mice were bred with mice carrying a floxed diphtheria toxin subunit A (DTA) gene, creat-
ing progeny (Ucp1-Cre, ROSA26DTA/+, referred to as Ucp1Cre+/DTA+) in which expression of UCP1 would drive 
intracellular expression of DTA, resulting in cell death. Confirming the efficacy of this model, at 4-weeks-old, 
Ucp1-Cre mediated expression of DTA led to complete ablation of BAT in the majority of the Ucp1Cre+/DTA+ mice 
(7/11 animals, Fig. 3a). Residual BAT in the remaining Ucp1Cre+/DTA+ mice was ~10% of the WT average. Inguinal 
and gonadal fat pad masses were equivalent between male Ucp1Cre+/DTA+ and control mice (Fig. 3b,c), however, 
female Ucp1Cre+/DTA+ mice displayed reduced iWAT and gWAT masses relative to their control littermates (−33% 
and −46%, respectively). Total body weight and tibia length were normal in male Ucp1Cre+/DTA+ mice, but reduced 
in female Ucp1Cre+/DTA+ mice, reflecting an overall reduction in body size in female but not male Ucp1Cre+/DTA+ 
Figure 3. Genetic ablation of Ucp1-Cre expressing cells results in loss of BAT but not BMAT. (a–c) Tissue 
weights for Ucp1Cre−/DTA (WT) and Ucp1Cre+/DTA brown adipose tissue (BAT), inguinal white adipose tissue 
(iWAT), and gonadal white adipose tissue (gWAT). (d) Ucp1Cre−/DTA and Ucp1Cre+/DTA mouse total body weight 
(BW). (e) Ucp1Cre−/DTA and UCP1Cre+/DTA tibia length measured by digital caliper. (f–h) Ucp1Cre−/DTA and 
Ucp1Cre+/DTA BAT, iWAT and gWAT tissue weights normalized to total body weight (BW). (i) Representative 
3-D images of osmium stained bones to visualize Ucp1Cre−/DTA (WT) and Ucp1Cre+/DTA (Ucp1) bone marrow 
adipose tissue (BMAT). Light grey is outline of bone. Dark grey is osmium-stained BMAT. Analysis and 3-D 
rendering of the μCT data sets were performed using Scanco software. (j–k) Regional analysis of osmium 
content in decalcified Ucp1Cre−/DTA and Ucp1Cre+/DTA tibias. (j) Proximal BMAT is osmium volume within 
the proximal epiphysis. (k) Distal BMAT is osmium volume from tibia-fibula junction to distal epiphysis. (l) 
Osmium content within the whole tibia bone marrow. Mean ± S.D. Two-tailed t-test, *P ≤ 0.05. Sample sizes: 
Male Cre- = 5–6, Male Cre +  = 4, Female Cre- = 7, Female Cre +  = 7. All ages were 4-weeks old.
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animals (Fig. 3d,e). Confirming a Ucp1-Cre-mediated and DTA-induced cell death, a reduction of BAT, iWAT 
and gWAT tissues compared to the Ucp1Cre-/DTA+ controls remained after normalization of tissue weights to body 
mass (Fig. 3f–h). To quantify BMAT in Ucp1Cre+/DTA+ mice, decalcified tibias were stained with osmium tetrox-
ide and imaged via microcomputed tomography (µCT, Fig. 3i). Regional analysis of BMAT volume was then 
performed and included the proximal epiphysis (rBMAT, Fig. 3j), distal tibia (cBMAT, Fig. 3k), and the total 
medullary cavity (Fig. 3l). Neither regional or total BMAT volume were reduced in Ucp1Cre+/DTA+ male or female 
mice. Instead, there was a slight trend toward increased BMAT volume in the distal BMAT and total BMAT 
measurements (Fig. 3k,l).
Adipocytes within the developing skeleton express adiponectin, but not UCP1, by lineage tracing. 
Expression of UCP1 in BMAT was then assessed using lineage tracing. Ucp1-Cre mice were crossed with mT/mG 
reporter mice to generate Ucp1Cre+/mTmG+ mice. In the presence of Cre, recombination leads to excision of tomato 
(RFP) and expression of GFP25. Thus, any cell having expressed Cre will change plasma membrane color from 
red to green. Adiponectin-Cre (Adipoq-Cre) mice were bred separately to mT/mG reporter mice (referred to as 
AdipoqCre+/mTmG+) to serve as a positive control for this experiment. Confocal imaging of RFP and GFP in BAT, 
iWAT, cBMAT (tail) and rBMAT was completed in male and female mice aged 3-weeks and 16-weeks (Fig. 4). 
Confirming the efficacy of these models, 100% of the BAT adipocytes and approximately 45% of iWAT adipocytes 
expressed GFP in Ucp1Cre+/mTmG+ mice (age 3-weeks, Fig. 4b). In the AdipoqCre+/mTmG+ mice, 100% of the BAT and 
iWAT adipocytes were GFP positive (Fig. 4b). GFP positive, Ucp1-Cre expressing cells could not be found among 
either cBMAT or rBMAT adipocytes (perilipin positive) of male or female mice (Fig. 4b). In contrast, all BMAT 
adipocytes, regardless of location, were GFP positive in the AdipoqCre+/mTmG+ mice.
ß3-adrenergic agonist CL316,243 does not induce UCP1 expression in adult BMAT. Treatment 
with ß3-adrenergic agonist CL316,243 is an established mechanism for inducing adipocyte beiging and UCP1 
expression in rodents26. To determine whether BMAT adipocytes express UCP1 after CL316,243 treatment in 
vivo, Ucp1-Cre-mediated GFP expression was evaluated in 16-week-old male and female Ucp1Cre+/mTmG+ reporter 
mice, following six days of 0.3 mg/kg CL316,243 treatment (Fig. 4c,d). AdipoqCre+/mTmG+ mice were used again as 
a positive control for GFP, and iWAT from CL316,243 treated mice served as positive control for Ucp1-cre medi-
ated GFP induction. Adipoq-Cre-mediated GFP was uniformly expressed in BAT, iWAT and BMAT adipocytes of 
male and female AdipoqCre+/mTmG+ mice, irrespective of CL316,243 treatment (Fig. 4c,d). Ucp1-Cre-mediated GFP 
was expressed in 100% of BAT adipocytes in both male and female Ucp1Cre+/mTmG+ (Fig. 4c,d). Approximately 27% 
of iWAT adipocytes in male saline-treated Ucp1Cre+/mTmG+ mice were GFP positive. With CL316,243 treatment, 
approximately 50% of iWAT adipocytes in male Ucp1Cre+/mTmG+ mice had Ucp1-Cre-mediated GFP expression, an 
85% increase. In female saline-treated Ucp1Cre+/mTmG+ mice, approximately 28% of the iWAT adipocytes were GFP 
positive, increasing to 37% after treatment with CL316,243. In the Ucp1Cre+/mTmG+ bone marrow, neither rBMAT or 
cBMAT adipocytes (perilipin positive) expressed Ucp1-Cre-mediated GFP, regardless of sex or CL316,243 treatment.
UCP1 and adiponectin mTmG reporter conversion occurs in non-adipocytes. To verify the spec-
ificity of the Ucp1Cre+/mTmG+ and AdipoqCre+/mTmG+ reporter mice, we also examined a subset of peripheral tissues. 
Liver, pancreas, spleen, lung, and intestine were negative for GFP expression in Ucp1Cre+/mTmG+ mice at 3- and 
16-weeks. However, there was notable Ucp1-Cre-mediated GFP expression in cells of the kidney collecting ducts. 
GFP expression in the kidneys of Ucp1Cre+/mTmG+ mice was present regardless of age, sex or CL316,243 treatment 
(Fig. 5a, male and female, 3- and 16-weeks-old, with and without CL316,243, n = 34 total). By contrast, kidney, 
liver, pancreas, spleen, lung, and intestine were negative for Adipoq-Cre-mediated GFP expression in all con-
ditions (AdipoqCre+/mTmG+ male, female, 3-week, 16-week, +/− CL316,243, n = 30 total). However, widespread 
Adipoq-Cre-mediated GFP expression was observed in the stromal reticular cell network of the bone marrow, 
cells lining blood vessels within bone, and bone-lining cells of the femur and tibia in all AdipoqCre+/mTmG+ mice 
regardless of age or treatment (Fig. 5b). As a control, neither the stromal reticular cell network of the bone mar-
row, vessel lining cells or bone lining cells expressed GFP in the Ucp1Cre+/mTmG+ mice. Gonadal tissue was also 
assessed at 16-weeks of age and was negative regardless of sex or CL316,243 treatment (n = 19, Ucp1Cre+/mTmG+; 
n = 18, AdipoqCre+/mTmG+).
Gene expression profiles in BMAT suggest enhanced roles in bone homeostasis and altered 
metabolism relative to WAT. To identify novel and emerging roles for BMAT adipocytes in both skeletal 
and whole-body homeostasis, we performed microarray analysis on white adipose tissues (inguinal and gonadal) 
and bone marrow adipose tissues from the proximal tibia, distal tibia, and radius/ulna of adult rabbits27,28. Unlike 
rodents, both rabbit and human bones have haversian canals, making this model of potentially increased rele-
vance to the human condition29. Like humans, rabbit bone marrow also develops extensive intramedullary BMAT 
which is concentrated around the central vascular cannals within the long bones27. Using a serial gene enrichment 
strategy, we identified 1,657 transcripts out of 9,158 that were enriched in regions of high BMAT (distal tibia 
and radius/ulna) relative to low BMAT (proximal tibia) (Fig. 6a,b). This included genes such as Wnt modulator 
Sfrp2, cell adhesion ligands such as Ibsp, and PTH receptor Pth1r, but not Ucp1 (Fig. 6b). Of these, 897 genes 
were differentially expressed relative to WAT and, of those, 775 were able to be mapped to corresponding human 
IDs for Inguinity pathway analysis (Supplementary Table 1). This revealed genetic evidence for differences in 
BMAT metabolism including decreased glycerol content, insulin resistance, decreased fatty acid metabolism, 
and decreased thermoregulation (Fig. 6c, full list in Supplementary Table 2). Genes related to lipid synthesis 
and transport pathways were also reduced in BMAT. Cellular pathway analysis suggested that this may be due to 
underlying reductions in fatty acid β-oxidation and oxidative phosphorylation (Fig. 6c). Degradation of biomol-
ecules including valine, catecholamines, and serotonin was also predicted to be reduced (Fig. 6c). Lastly, genes 
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Figure 4. Adipocytes within the developing skeleton express adiponectin, but not UCP1, by lineage tracing. 
(a) Representative images of AdipoqCre+/mTmG+ and UCP1Cre+/mTmG+ inguinal white adipose tissue (iWAT), 
constitutive bone marrow adipose tissue (cBMAT, caudal vertebrae), and regulated bone marrow adipose 
tissue (rBMAT, tibia). The presence of green (GFP-positive) cells indicates expression of Cre and conversion 
of the mTmG reporter. White boxes in images show inset for images to the right (GFP/RFP). Far right images 
(perilipin) demonstrate that the adipocytes in the GFP/RFP images are perilipin-positive. Images were acquired 
at 10X, scale bar is 50 µm or 25 µm for insets. (b–d) Quantification of Adipoq-Cre or Ucp1-Cre-mediated 
GFP expression in adipocytes relative to total number of adipocytes. White bars are the percent of adipocytes 
expressing GFP. Grey bars are the percent of adipocytes that do not express GFP (instead express RFP). Tissues 
collected from 3-week-old male and female mice (b) 16-week-old males (C) or females (d) treated with saline 
(−) or 0.3 mg/kg CL316,243 (CL) for 6-days. (b–d) Mean ± S.D. Sample sizes: (b) n = 5–6 (c) n = 3–5, (d) 
n = 3–7.
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Figure 5. UCP1 and adiponectin mTmG reporter conversion occurs in non-adipocytes. (a) Representative 
images of kidneys from 16-week-old Ucp1Cre+/mTmG+ and AdipoqCre+/mTmG+. The presence of green (GFP-
positive) cells in Ucp1Cre+/mTmG+ images indicates expression of Cre and conversion of the mTmG reporter 
in kidney collecting ducts (non-adipocytes) of Ucp1Cre+/mTmG+ mice. Numbered white boxes show inset for 
numbered images to the right. Dashed boxes in the bottom left (AdipoqCre+/mTmG+) image show targeted 
expression of Adipoq-Cre in peri-renal adipocytes. Images were acquired at 10x then stitched together, scale 
bars are 1 mm and 200 µm. (b) Representative images of bone marrow from 16-week-old Ucp1Cre+/mTmG+ 
and AdipoqCre+/mTmG+ mice. The presence of green (GFP-positive) cells in AdipoqCre+/mTmG+ images indicates 
expression of Cre and conversion of the mTmG reporter in bone lining cells (white arrowheads), cells along 
blood vessels, and cells along bone marrow reticular fibers of AdipoqCre+/mTmG+ mice. Numbered white boxes 
show inset for numbered images to the right. “B” indicates location of bone. “BV” indicates location of blood 
vessels. Images were acquired at 10X, scale bars are 50 µm and 25 µm.
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involved in skeletal pathways related to decreased bone mineral density were enriched in BMAT. Of these, the 
osteopontin gene Spp1 was among the most differentially expressed relative to WAT and had among the highest 
transcript levels detected (Fig. 6d). Thus, to validate our array and determine whether Spp1 was differentially 
expressed in the BMAT adipocyte itself, we performed qPCR analysis of purified BMAT and iWAT adipocytes 
from rats. Comparable to rabbit whole tissues, we found that expression of Spp1 was 15-fold higher in puri-
fied BMAT adipocytes relative to iWAT (Fig. 6e). Lastly, we visualized osteopontin expression at the protein 
level in human skeletal biopsies. Consistent with previous reports30, we observed robust staining for osteopontin 
within the bone matrix along the cement lines and around the osteocytes (Fig. 6f). When present, bone lining 
cells were also noted to be positive. In many regions, BMAT adipocytes were situated immediately adjacent to 
osteopontin-rich bone surfaces and, in some cases, demonstrated faint cytoplasmic reactivity (Fig. 6f).
Discussion
In healthy individuals, BMAT can occupy up to 70% of the medullary cavity and accounts for ~8% of total body 
fat1,6. Despite the abundance of BMAT, its function remains unclear. The concept of BMAT functioning as an 
energy depot, similar to WAT adipocytes, seems relevant in areas of high hematopoietic activity and bone turno-
ver, such as the proximal tibia and distal femur (rBMAT region), and is supported by recent publications. Electron 
Figure 6. BMAT gene enrichment analysis. (a) Gene enrichment and analysis strategy. Of 9,158 detected 
transcripts, 1,657 were significantly increased in regions of high BMAT (distal tibia and radius/ulna) relative 
to low BMAT (proximal tibia). (b) Of these, 897 were differentially expressed relative to WAT (blue dots, full 
dataset in Supp Table 1). (c) Rabbit gene IDs of these differentially expressed transcripts were converted to 
human identifiers and used for Inguinity Pathway Analysis (full list available in Supp Table 2). (d) Linearized 
values for osteopontin (Spp1) transcript expression from rabbit whole tissues. 1-way-ANOVA with Tukey’s 
multiple comparisons test, *p < 0.05. (e) Spp1 transcript from purified inguinal white adipose tissue (iWAT) 
and tail bone marrow adipocytes (BMAT) normalized to the geometric mean of reference genes Tbp and Ppia. 
Two-tailed t-test. *p < 0.05. (f) Representative osteopontin immunohistochemistry of human bone and bone 
marrow. B = bone, Ad = bone marrow adipocytes, white arrows = osteopontin immunostaining in bone (pink), 
black arrows = osteopontin immunostaining in bone marrow (pink). Scale bar is 50 µm.
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microscopy (EM) studies have shown BMAT adipocytes to interact with myeloid/granulocyte cells and erythro-
blast islands11. The same EM study showed extensions of lipid droplet-filled cytoplasm from BMAT adipocytes 
adjacent to active osteoblasts11. By contrast, regions of confluent constitutive BMAT adipocytes are selectively 
retained and often resist conventional lipid mobilization cues (reviewed in31). Our microarray study provides a 
novel list of 897 candidate genes that may underlie these functional relationships and differences in metabolic 
responsiveness (Fig. 6, Supplementary Table 1). Beyond this, in pathologic conditions, BMAT adipocytes have 
been shown to facilitate and fuel bone tumor progression (reviewed in32). Less clear is whether BMAT adipocytes 
also have ‘beige’-like properties, more specifically, whether these adipocytes express UCP1 and therefore have 
the capacity for thermogenesis. Several attempts have been made to determine whether BMAT adipocytes do 
indeed express UCP1, but collectively have yielded conflicting results. To overcome this, we sought to track UCP1 
expression in BMAT at the single cell level using multiple rodent models.
Deciphering whether BMAT adipocytes express UCP1 is of importance because it informs the function of 
these cells. The capacity of BMAT adipocytes to undergo UCP1-mediated adaptive thermogenesis would have 
multiple advantages. First, positioning of thermogenic cells within stem cell niches may protect hematopoietic 
cells and therefore blood cell production from cold exposure in distal appendages. Second, the shunting of energy 
substrates toward adaptive thermogenesis has the benefit of lowering glucose and lipid load. Thus, clearance of 
lipids via adaptive thermogenesis may also protect hematopoietic and bone remodeling niches from lipotoxicity. 
As previously discussed, several lines of evidence both support and refute the existence of UCP1 expression in 
BMAT adipocytes. Briefly, Ucp1 transcript has been detected in whole bone RNA preparations14–17, however, this 
type of tissue preparation is susceptible to contamination by adipocytes near the periosteal surface which we now 
show have the potential to express UCP1 (Fig. 2). Further, comparison of Ucp1 transcript amount in these bone 
preparations is >10,000 fold less when compared to BAT14,16. It is also unknown whether Ucp1 transcript would 
result in UCP1 protein expression. One report did show putative UCP1 protein expression by IHC in comparable 
appearing, ‘multilocular’ BMAT adipocytes within the lumbar vertebrae of 3-week old mice18. However, in this 
report, we show that immunostaining of bone marrow can easily provide false positive results, particularly in the 
absence of UCP1-KO tissue controls (Fig. 2). There are also reports that UCP1 protein is not expressed in BMAT, 
even after beiging induction by methionine-restriction20,23.
In this study, three approaches were taken to specifically address whether BMAT adipocytes have the potential 
for UCP1 expression: 1) immunohistochemical detection of UCP1 protein in intact tissue, 2) Ucp1-Cre-driven 
and DTA-mediated cell ablation, and 3) Ucp1-Cre-mediated lineage tracing. Immunohistochemistry for UCP1 
expression provided inconclusive results. Specifically, while cBMAT adipocytes were clearly negative, non-specific 
DAB precipitation was present in hematopoietic-rich bone marrow of both control and UCP1-knockout mice 
making UCP1 expression in rBMAT cells difficult to assess. However, Ucp1-Cre driven cell ablation and lineage 
tracing provided compelling data that BMAT adipocytes, regardless of subregion, do not express UCP1. Ucp1-Cre 
driven expression of DTA resulted in loss of brown adipocytes and a subpopulation of iWAT adipocytes, but 
there was no detectable loss of BMAT adipocytes as assessed by 3-dimensional, regional analysis of BMAT in 
the proximal tibia, distal tibia and whole tibia. While these experiments cannot rule out the possibility of a loss 
of a Ucp-1 positive population that is replaced by a Ucp-1 negative BMAT population this possibility is not sup-
ported by our lineage tracing experiments. Lineage tracing using Ucp1-Cre and the mTmG reporter found that 
Ucp1-Cre successfully induced GFP expression in BAT and subpopulations of iWAT but did not induce GFP 
expression in BMAT of the femur, tibia or tail vertebrae regardless of age, sex, or induction by beiging factor 
CL316,243. A limitation of reporter models is that they rely on induction of the Ucp1-Cre. Cre recombinase mod-
els can have off-target expression or insufficient recombination. However, it is unlikely that these concerns would 
change the outcome of our study. First, there was no detectable difference in BMAT volume in the Ucp1Cre+/DTA+ 
model nor GFP-positive BMAT in Ucp1Cre+/mTmG+ mice, ruling out mis-expression in BMAT. Second, sufficient 
Ucp1-Cre-mediated recombination is supported by loss of peripheral brown and beige adipocytes in Ucp1Cre+/
DTA+ mice, and conversion of the mTmG reporter in these adipocytes, as well as subpopulations of adipocytes 
near the periosteal surface in Ucp1Cre+/mTmG+ mice. Further, conversion of the mTmG reporter by the Adipoq-Cre 
served as a positive control for the ability of BMAT adipocytes to support Cre-mediated recombination.
Lack of UCP1 expression despite a multilocular morphology could indicate that BMAT adipocytes transi-
tion from an early multilocular stage to a mature unilocular morphology; a physiologic transition similar to the 
fusion of immature lipid droplets in white adipocytes (reviewed in24). In this report, we show that the frequency 
of multilocular BMAT adipocytes is comparable across anatomical sites and is preserved between ages 3-weeks 
to 9-weeks old (~5%). Also, that this frequency is comparable to that reported for 12-week-old C3H/HeJ mice7. 
Together, these findings indicate that ‘multilocularity’ is stable across age and mouse strain. If adipocytes transi-
tion through a multilocular state, then it can be extrapolated that BMAT adipocyte turnover occurs at constant 
rate despite location or age. In addition, multilocularity could imply that these cells are undergoing simulated 
lipid droplet remodeling (lipolysis) and therefore have the ability to function as a local fuel reservoir. In support 
of this hypothesis, we recently demonstrated, using electron microscopy, that BMAT adipocytes directly interact 
with cells of the myeloid/granulocyte lineage, erythroblast islands, and active osteoblasts11. Additionally, there are 
published reports showing BMAT provides fuel to cancer cells (reviewed in32) and that inflammatory arthritis is 
associated with BMAT depletion33. As demonstrated by our microarray analysis and previous reports7,28,34, the 
regulation of BMAT energy storage and partitioning is unique when compared to peripheral WAT. For example, 
pathway analysis indicated that BMAT likely has reduced quantity of glycogen relative to WAT, a finding that has 
previously been demonstrated by electron microscopy during BMAT adipogenesis34. BMAT was also noted to be 
insulin resistant, which has recently been confirmed in both rodents and humans28.
Lastly, lineage tracing studies have yielded mixed results regarding identification of a ‘beige’-like BMAT adi-
pocyte. Specifically, BMAT adipocytes have been shown to express PdgfRα, a mediator of adipocyte progenitor 
commitment to a beige adipocyte19, following irradiation or rosiglitazone treatment (discussed in20). However, 
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myogenic factor-5 (Myf5), which is expressed in the majority of brown adipocyte progenitors and a minority of 
beige progenitors21,22, was not detected in BMAT progenitors (discussed in20). In our study, lineage tracing clearly 
showed that BMAT adipocytes express the adipocyte marker adiponectin, but do not express the traditional beige 
cell marker Ucp1. However, Ucp1-Cre mediated conversion of the mTmG reporter did show Ucp1-Cre expression 
in cells of the kidney collecting ducts. Assessment of UCP1 expression in the mouse kidney has been evaluated 
by other labs. There is one report supporting UCP1 expression in mouse kidney35, however, there are multiple 
reports indicating mammalian kidneys do not express UCP136–38. Thus, this is a point that warrants further clar-
ification. Similarly, though Adipoq-Cre is not expressed in the stromal vascular fraction of adipose tissue39 or 
skin stromal cells40, AdipoqCre+/mTmG+ mice demonstrated prevalent Adipoq-Cre expression in bone lining cells, 
perivascular cells within bone, and cells within the reticular stromal network, a finding consistent with other 
reports41,42. This continuity of expression between the stromal-reticular network and BMAT is also emphasized 
in our microarray data. Specifically, we chose to examine osteopontin (Spp1) since it was one of the most highly 
expressed transcripts in our enrichment analysis (#5/897) and was also among the most differentially expressed 
relative to WAT (~90-fold higher). We also found evidence of differential Spp1 expression in purified rat BMAT 
adipocytes relative to iWAT. Osteopontin (Spp1) is broadly expressed across tissues43, including bone marrow 
stromal and lining cells30,44 and adipocytes43. There is evidence for both secreted and cell-autonomous functions 
with downstream impacts on mineralization, lipid metabolism, and metastasis43,45–47. Future work needed to 
clarify the role of Spp1 and other candidate genes at the BMAT cell level across species and to characterize their 
contribution to BMAT function.
Conclusion
Our data demonstrate that BMAT does not express UCP1 during development, in maturity, or after β3-agonist 
treatment. This provides important information about the origin and potential functions of BMAT. Though our 
data largely rules out the potential for UCP1-mediated thermogenesis in BMAT adipocytes, UCP1-independent 
mechanisms for adaptive thermogenesis have recently been described in both adipose tissue and muscle and war-
rant additional investigation. Specifically, lipid and creatine cycling are mechanisms allowing UCP1-independent 
thermogenesis in fat48, while calcium cycling has been shown to support alternative thermogenesis in both fat 
and muscle49–52. It should also be considered that BMAT represents a unique subtype of adipose tissue with endo-
crine and paracrine functions distinct from both brown and white adipose tissues. Clarification of the genes and 
proteins expressed by BMAT adipocytes will advance our understanding of BMAT function and its regulation in 
both health and disease.
Materials and Methods
Animal models and use. Institutional guidelines for the handling and experimentation with animals 
were followed for this study. Mouse studies were approved by the animal use and care committee at Washington 
University (Saint Louis, MO, USA). To generate Ucp1-Cre, ROSA26DTA/+ (Ucp1Cre+/DTA+) animals, heterozygous 
Ucp1-Cre+ males (Jackson Labs #024670) were bred to female diphtheria toxin subunit A (ROSA26DTA/DTA) 
homozygous mice (Jackson Labs #009669). Due to loss of brown adipose tissue and impaired thermoregula-
tion, Ucp1Cre+/DTA+ animals do not survive when born at room temperature and thus were bred and housed at 
thermoneutrality (30 °C). Ucp1Cre+/DTA+ animals have a head tilt phenotype. Given there is no change in BMAT 
volume in Ucp1Cre+/DTA+ animals, this finding does not affect the conclusions of this paper. To generate Ucp1-
Cre, ROSA26mTmG/+ and Adipoq-Cre, ROSA26mTmG/+ (Ucp1Cre+/mTmG+ and AdipoqCre+/mTmG+) animals, heterozy-
gous Ucp1-Cre+ or Adipoq-Cre+ males (Jackson Labs #024670 and #028020) were bred to homozygous mTmG 
(ROSA26mTmG/mTmG) female mice (Jackson Labs #007676). Ucp1Cre+/mTmG+ or AdipoqCre+/mTmG+ reporter animals 
have no deficiencies in thermoregulation and were thus bed and housed under standard conditions at 22 °C. 
All transgenic mice were maintained on an a C57BL/6J background (Jackson Labs #000664). All animals were 
housed in a vivarium with a 12-hour light/dark cycle and fed standard chow ad libitum (PicoLab 5053, LabDiet).
Rabbit and rat studies were approved by the University of Michigan Committee on the Use and Care of 
Animals. Housing, monitoring, and euthanasia information for both the rabbits27 and rats4 included in this 
study has been previously reported. Briefly, male New Zealand White rabbits from Harlan Laboratories (Haslett, 
MI, USA) were euthanized at two ages, 13-weeks and 22-weeks, for tissue collection and analysis. Rabbit care 
was provided by the Unit for Latoratory Animal Medicine. Rabbits were housed at 22 °C on a 12-hour light/
dark cycle and fed high-fiber diet (LabDiet: 5326) ad libitum (13-week old rabbits, body mass 2.70 ± 0.06 kg, 
n = 6) or a measured 100 g/day starting at 15-weeks of age (22-week old rabbits, body mass 3.17 ± 0.09 kg, n = 5). 
Sixteen-week-old male Sprague–Dawley rats were obtained from Charles River Laboratories (strain code: 400). 
Rats were were housed at 22 °C on a 12-hour light/dark cycle and fed standard chow.
CL316,243 treatment regimen. Male and female Ucp1Cre+/mTmG+ and AdipoqCre+/mTmG+ reporter animals 
aged 15-weeks received six 0.03 mg/kg CL316,243 (Sigma) or saline injections over the course of eight days. 
On the ninth day, animals were perfused with 10% buffered formalin and tissues collected. 12-week-old C3H/
HeJ mice received 5 µg CL316,243 injections daily for 3 days. After 72-hours, mice were euthanized and tissues 
collected.
Tissue collection (mouse). Following euthanasia, brown adipose tissue (BAT), inguinal white adipose tis-
sue (iWAT), gonadal white adipose tissue (gWAT) and tibias were collected from Ucp1Cre+/DTA+ animals. Tibia 
length was determined using a digital caliper. Tibias were post-fixed for 24-hours then decalcified in 14% EDTA, 
pH 7.4 for 3 weeks. Tissues from 3-week and 9-week-old C57BL/6J mice for paraffin embedding were post-fixed 
for 24-hours in 10% neutral buffered formalin (NBF) then stored in PBS. Prior to collection of Ucp1Cre+/mTmG+ 
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and AdipoqCre+/mTmG+ tissues, mice were perfused with 10% NBF. Harvested tissues were then post-fixed for an 
additional 24-hours in 10% NBF. Paraffin embedding was performed by the WUSM Musculoskeletal Histology 
and Morphometry Core. All paraffin sections were 5 µm thick. Prior to embedding, bones were decalcified in 14% 
EDTA, pH 7.4 for 2-weeks.
Biopsy specimens (human). Human control biopsies from the iliac crest were included from the patholog-
ical biobanks at Vejle Hospital in accordance with the approval by the Danish National Committee on Biomedical 
Research Ethics, journal no. S-20070121, as described previously53. The biopsies were diagnostic jamshidi biop-
sies obtained from patients formerly undergoing an examination for a hematological disorder, showing no skel-
etal disorders. The biopsies included in the study originated from patients not receiving any prior medications 
known to affect the bones and not declining use of their tissues for research in the National Tissue Application 
Register. The biopsies were blinded after inclusion (sex and age unknown).
Paraffin immunohistochemistry. Prior to hematoxylin/eosin or immunohistochemistry, sections were 
deparaffinized in xylene and hydrated in an ethanol gradient and distilled water.
Perilipin and endomucin immunohistochemistry (mouse) was performed as described previously11. Briefly, 
antigen retrieval was performed in 10 mM sodium citrate buffer (pH 6.0, 20-minutes, 90-95 °C) prior to per-
meabilization in 0.2% Triton-X in PBS and block in 10% donkey serum in TNT buffer (0.1 M Tris-HCL pH 
7.4, 0.15 M sodium chloride, 0.05% Tween-20). Sections were co-stained with antibodies against endomucin 
(BioLegend, 1:500) and perilipin (1:400, Progen GP29) in TNT buffer containing 2.5% donkey serum overnight 
at 4 °C. Secondary antibodies (1:200 donkey anti guinea pig Cy3 and 1:200 donkey anti rat Alexa 488; Jackson 
ImmunoResearch) in TNT buffer were applied for 1-hour at room temperature. All washes between steps were 
performed in TNT buffer. Nuclei were counterstained with 1 μg/mL DAPI (Sigma). Slides were imaged on an 
Olympus FV1200 confocal microscope.
For UCP1 immunohistochemistry (mouse), tissue samples were permeabilized for 10-minutes and blocked for 
1.5-hours with the buffer provided from Vectastain Elite ABC kit (Vector Laboratories). Primary antibody cock-
tail (1:2,000 UCP1, Abcam polyclonal ab10983) was made in TNT buffer containing 2% donkey serum and incu-
bated overnight at 4 °C. Tissue sections were washed in TNT followed by quenching of endogenous peroxidases 
with 0.3% hydrogen peroxide in PBS for 30-minutes. Sections were washed 3x again in TNT prior to incubation 
with kit-provided secondary antibody (ImPRESS) for 30-minutes. After the secondary antibody, tissue samples 
were again washed 3x in TNT and 2x in PBS. Tissues were incubated with DAB substrate solution for 30-seconds 
for stain development, then washed in water. After a final wash, samples were stained with hematoxylin, dehy-
drated through a reverse ethanol gradient and mounted with Permount mounting media. Images were acquired 
using Nanozoomer 2.0-HT system.
For osteopontin (SPP1) immunohistochemistry (human), antigen retrieval was performed by heating samples 
in Tris/EDTA (pH 9.0) for overnight at 60 °C. Tissue sections were blocked for 20 minutes using 1% casein in 
TNT buffer. Primary antibody (1:25 osteopontin, R&D Systems, BAF1433) was made in TNT buffer contain-
ing 1% casein and incubated 1-hour at room temperature. Secondary antibody (1:50 donkey anti Goat Alkaline 
Phosphatase, Jackson ImmunoResearch 705-056-147) was made in TNT buffer and incubated for 30 minutes at 
room temperature. Chromogen staining was made with Liquid Permanent Red (DAKO). All washes between 
steps were performed in TNT buffer. Nuclei were counterstained with Meyer hematoxylin. Slides were imaged 
using an upright DMRXAZ microscope (Leica) and a UC30 camera (Olympus).
Quantification of multilocular bone marrow adipocyte frequency was performed on H&E stained tibia and 
femur sections from 3-week and 9-week-old C57BL/6J mice. As previously described7, BMAT adipocytes were 
considered multilocular if they contained three or more smaller lipid droplets associated with a large lipid droplet. 
All adipocytes within the epiphysis (distal for femur, proximal for tibia), metaphysis (mid-diaphysis to growth 
plate for femur, growth plate to tibia-fibula junction for tibia), or distal tibia were counted. Two tissue sections per 
mouse were analyzed and the data averaged.
Frozen immunohistochemistry. Ucp1Cre+/mTmG+ and AdipoqCre+/mTmG+ reporter animals were anesthetized 
with ketamine/xylazine cocktail (80 mg/kg and 5 mg/kg, respectively) perfused with 10% NBF prior to euthana-
sia. Harvested tissues were post-fixed for 24-hours in 10% NBF then washed in PBS. Bones were decalcified using 
14% EDTA, pH 7.4 for 14-days. Tissues were embedded in OCT mounting media and sectioned at 50μm (tibia, 
iWAT, kidney) or 100μm (tail) using a cryostat (Leica). Tissue sections were rinsed 3x in TNT and blocked for 
1-hour with 10% donkey serum in TNT buffer (0.1 M Tris-HCL pH 7.4, 0.15 M sodium chloride, 0.05% Tween-
20). Primary antibody cocktail (1:1,000 chicken anti-GFP; 1:500 rabbit anti-RFP; 1:1,000 guinea pig anti-perilipin; 
Abcam ab13970, ab62341 and Progen GP29, respectively) was made in TNT buffer and incubated overnight at 
4 °C. Secondary antibody cocktail (1:500 donkey anti-guinea pig Alexa 647; 1:500 donkey anti-chicken Alexa 
488; 1:500 donkey anti-rabbit Alexa 594; Jackson ImmunoResearch 706-605-148, 703-545-155, and 711-585-152 
respectively) was made in TNT buffer and incubated for 24-hours at 4 °C. Images were acquired using a Nikon 
Spinning Disk confocal microscope. Quantification of GFP/RFP positive adipocytes was performed in iWAT, 
gWAT, BAT and three regions of BMAT including tail vertebrae, femur, and proximal tibia (Fig. 4 and data not 
shown). All perilipin positive adipocytes in a full length, 50–100 μm section were assessed for each animal.
Osmium staining and micro-computed-tomography (µCT). Tibias from 4-week-old Ucp1Cre+/DTA+ 
and littermate controls were decalcified in 14% EDTA, pH 7.4 for 3-weeks then stained with osmium tetroxide 
and imaged as described previously54. Briefly, decalcified bones were incubated in a PBS solution containing 
1% osmium tetroxide (Electron Microscopy Sciences) and 2.5% potassium dichromate (Sigma) for 48-hours. 
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Following thorough washing, osmium-stained bones were embedded in 2% agarose and scanned a 10 µm voxel 
resolution using a Scanco μCT 40 (Scanco Medical AG). Analysis and 3-D rendering of the μCT data sets were 
performed using Scanco software, and a threshold of 400. Analysis regions included the tibia proximal epiphysis, 
distal tibia (tibia-fibula junction to distal epiphysis) and total medullary cavity.
Microarray enrichment analysis (rabbit). RNA was isolated from whole white adipose tissues (inguinal, 
iWAT; gonadal, gWAT) and bone marrow adipose tissues (distal tibia, dBMAT; radius/ulna, ruBMAT; proximal 
tibia, pBMAT) of rabbits as described previously27. Briefly, rabbit tissues were frozen on dry ice, pulverized in 
liquid nitrogen with a mortar and pestle, and lysed in Stat60 reagent (Tel-Test Inc) by manual disruption with 
a needle and syringe. For microarray, purified rabbit RNA was digested on-column with DNase I and cleaned 
using the Qiagen RNeasy kit (Qiagen) as recommended by the manufacturer. Total RNA was then submitted to 
the microarray core at the University of Michigan. The samples were screened for quality and processed in the 
microarray facility using custom rabbit Affymetrix arrays and the IVT Express kit (Affymetrix). Samples that did 
not meet minimum RNA quality or concentration standards were excluded from microarray analysis. As a QC 
measure, the distribution of probe intensities and the 5’ to 3’ degradation profiles were checked to be consistent 
across samples. The core’s statistician used RMA, from the Affy package of bioconductor, to fit log2 expression 
values to the data55. Weighted, paired, linear models were then fit and contrast computed using the limma pack-
age56. Weighting was done using a gene-by-gene algorithm designed to down-weight chips that were deemed 
less reproducible57. Probe-sets with a variance over all samples less than 0.05 were filtered out, leaving 9,158 
transcripts for analysis across both cohorts (Fig. 6a). The data discussed in this publication have been deposited 
in NCBI’s Gene Expression Omnibus58 and are accessible through GEO Series accession number GSE138690. To 
enrich for BMAT adipocyte-associated transcripts, gene expression in regions of high BMAT content (distal tibia 
BMAT and radius/ulna BMAT) were compared to a region of relatively decreased BMAT (proximal tibia BMAT). 
P-values were adjusted for multiple comparisons using the Holm-Sidak method with alpha set at 0.05, resulting in 
identification of 1,657 transcripts that were statistically enriched in regions of high BMAT. From there, expression 
of these transcripts in BMAT (all dBMAT and ruBMAT) was compared to all white adipose tissues (all gWAT 
and iWAT) to generate a list of genes with high probability of differential expression between BMAT and WAT. 
As before, P-values were adjusted using the Holm-Sidak method and 897 transcripts were retained for further 
pathway analysis (Fig. 6a, Supplemental Table 1). To ensure maximum compatibility with the Inguinity Pathway 
Analysis software, rabbit gene identifiers were converted to their corresponding human homologues using the 
‘BetterBunny’ algorithm59. Homology-based human IDs were identified for 775 out of 897 genes which were then 
used for pathway analysis (Fig. 6a, Supplemental Table 1).
Adipocyte purification and qPCR analysis (rat). Cell isolation, RNA purification, and qPCR analysis 
was completed as previously described4. Briefly, twelve 16-week-old male Sprague–Dawley rats were used to 
purify and isolate 6 BMAT adipocyte samples from caudal vertebrae (two animals pooled per sample) and 12 
floated adipocyte preparations from inguinal WAT (one animal per sample) using a modified collagenase diges-
tion protocol4. Floated adipocytes were collected and lysed using Stat60 reagent (Amsbio, Cambridge, MA, USA) 
to isolate total RNA. RNA was reverse-transcribed to cDNA (Applied Biosystems, Carlsbad, CA) and quantitative 
PCR was performed using qPCRBIO SyGreen mix, Hi-Rox, on an Applied Biosystems real-time PCR detection 
system. Gene expression was calculated based on a cDNA standard curve within each plate and normalized to 
the expression of the geometric mean of TATA-binding protein (Tbp) and cyclophilin A (Ppia) messenger RNA.
Statistics. Statistical analysis was performed using GraphPad Prism (GraphPad Software). Statistical tests are 
detailed in the corresponding figure legend. A p-value of <0.05 was considered statistically significant.
Data availability
All data contained within this manuscript are available upon request.
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